Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.
In a rare bipartisan moment, the House passed legislation Thursday that would extend temporary protections for Haitian ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果